JP2017511329A5 - - Google Patents

Download PDF

Info

Publication number
JP2017511329A5
JP2017511329A5 JP2016560389A JP2016560389A JP2017511329A5 JP 2017511329 A5 JP2017511329 A5 JP 2017511329A5 JP 2016560389 A JP2016560389 A JP 2016560389A JP 2016560389 A JP2016560389 A JP 2016560389A JP 2017511329 A5 JP2017511329 A5 JP 2017511329A5
Authority
JP
Japan
Prior art keywords
oxy
amine
dimethylpentan
methyl
difluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016560389A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017511329A (ja
JP6411541B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/023805 external-priority patent/WO2015153720A1/en
Publication of JP2017511329A publication Critical patent/JP2017511329A/ja
Publication of JP2017511329A5 publication Critical patent/JP2017511329A5/ja
Application granted granted Critical
Publication of JP6411541B2 publication Critical patent/JP6411541B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016560389A 2014-04-02 2015-04-01 ビアリールキナーゼ阻害剤 Active JP6411541B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461973942P 2014-04-02 2014-04-02
US61/973,942 2014-04-02
US201462061591P 2014-10-08 2014-10-08
US62/061,591 2014-10-08
PCT/US2015/023805 WO2015153720A1 (en) 2014-04-02 2015-04-01 Biaryl kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2017511329A JP2017511329A (ja) 2017-04-20
JP2017511329A5 true JP2017511329A5 (cg-RX-API-DMAC7.html) 2018-03-15
JP6411541B2 JP6411541B2 (ja) 2018-10-24

Family

ID=52988448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016560389A Active JP6411541B2 (ja) 2014-04-02 2015-04-01 ビアリールキナーゼ阻害剤

Country Status (27)

Country Link
US (7) US9902722B2 (cg-RX-API-DMAC7.html)
EP (1) EP3126351B1 (cg-RX-API-DMAC7.html)
JP (1) JP6411541B2 (cg-RX-API-DMAC7.html)
KR (1) KR102379518B1 (cg-RX-API-DMAC7.html)
CN (1) CN106458994B (cg-RX-API-DMAC7.html)
AU (1) AU2015240869B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016022298B1 (cg-RX-API-DMAC7.html)
CA (1) CA2944466C (cg-RX-API-DMAC7.html)
CL (1) CL2016002502A1 (cg-RX-API-DMAC7.html)
CY (1) CY1120988T1 (cg-RX-API-DMAC7.html)
DK (1) DK3126351T3 (cg-RX-API-DMAC7.html)
EA (1) EA028942B1 (cg-RX-API-DMAC7.html)
ES (1) ES2700549T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20181899T1 (cg-RX-API-DMAC7.html)
HU (1) HUE041457T2 (cg-RX-API-DMAC7.html)
IL (1) IL248086B (cg-RX-API-DMAC7.html)
LT (1) LT3126351T (cg-RX-API-DMAC7.html)
MX (1) MX2016012829A (cg-RX-API-DMAC7.html)
PE (1) PE20170004A1 (cg-RX-API-DMAC7.html)
PL (1) PL3126351T3 (cg-RX-API-DMAC7.html)
PT (1) PT3126351T (cg-RX-API-DMAC7.html)
RS (1) RS58062B1 (cg-RX-API-DMAC7.html)
SG (1) SG11201608195QA (cg-RX-API-DMAC7.html)
SI (1) SI3126351T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201800665T1 (cg-RX-API-DMAC7.html)
WO (1) WO2015153720A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201606767B (cg-RX-API-DMAC7.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10253027B2 (en) 2013-07-08 2019-04-09 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
US9737542B2 (en) 2013-10-11 2017-08-22 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
CN106164066B (zh) 2014-02-13 2020-01-17 因赛特公司 作为lsd1抑制剂的环丙胺
JP6602779B2 (ja) 2014-02-13 2019-11-06 インサイト・コーポレイション Lsd1阻害剤としてのシクロプロピルアミン類
US9527835B2 (en) 2014-02-13 2016-12-27 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
HRP20181899T1 (hr) * 2014-04-02 2019-01-11 Bristol-Myers Squibb Company Biaril inhibitori kinaze
US9695168B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
TW201613925A (en) 2014-07-10 2016-04-16 Incyte Corp Imidazopyrazines as LSD1 inhibitors
CN107660205B (zh) 2015-04-03 2021-08-27 因赛特公司 作为lsd1抑制剂的杂环化合物
ES2740224T3 (es) * 2015-04-10 2020-02-05 Bristol Myers Squibb Co 6H-isocromeno[3,4-c]piridinas y benzo[c][1,7]naftiridin-6-(5H)-onas como inhibidores de la cinasa asociada a adaptador 1 (AAK1)
EA035534B1 (ru) 2015-08-12 2020-06-30 Инсайт Корпорейшн Соли ингибитора lsd1
US10544120B2 (en) * 2015-10-01 2020-01-28 Bristol-Myers Squibb Company Biaryl kinase inhibitors
US10246469B2 (en) * 2015-10-01 2019-04-02 Bristol-Myers Squibb Company Biaryl kinase inhibitors
WO2018139436A1 (ja) 2017-01-24 2018-08-02 住友化学株式会社 縮合複素環化合物及びそれを含有する組成物
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
TW202120495A (zh) * 2019-08-02 2021-06-01 美商愛彼特生物製藥股份有限公司 經取代環丙基—2,2'—聯嘧啶基化合物、其類似物及其使用方法
CN115484951A (zh) * 2020-04-21 2022-12-16 莱西肯医药有限公司 用于治疗病毒感染的aak1抑制剂
US11666575B2 (en) 2020-04-21 2023-06-06 Lexicon Pharmaceuticals, Inc. Pyrazolo[1,5]pyrimidine-based compounds and methods of their use to treat viral infections
CN115697968B (zh) * 2020-05-28 2024-03-29 杭州中美华东制药有限公司 (s)-2-氨基-3-(4-(2,3-二甲基吡啶-4-基)苯基丙酸甲酯及其盐的制备方法
TW202210461A (zh) * 2020-05-28 2022-03-16 中國大陸商杭州中美華東製藥有限公司 一種(s)—2—胺基—3—(4—(2,3—二甲基吡啶—4—基)苯基)丙酸甲酯二酸鹽的製備方法
WO2023284838A1 (zh) * 2021-07-15 2023-01-19 四川海思科制药有限公司 Aak1抑制剂及其用途
WO2023051749A1 (zh) * 2021-09-30 2023-04-06 武汉人福创新药物研发中心有限公司 Aak1抑制剂及其用途
US12344596B2 (en) * 2022-03-01 2025-07-01 Lexicon Pharmaceuticals, Inc. Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof
CA3244394A1 (en) * 2022-03-01 2023-09-07 Lexicon Pharmaceuticals, Inc. METHODS AND COMPOUNDS USEFUL IN THE SYNTHESIS OF AN AAK1 INHIBITOR
CA3246512A1 (en) 2022-03-23 2023-09-28 Assia Chemical Industries Ltd. SOLID FORMS OF LX9211 AND THEIR SALTS
CN120202001A (zh) * 2022-11-10 2025-06-24 西藏海思科制药有限公司 一种含aak1抑制剂的药物组合物
CN120344529A (zh) * 2022-12-13 2025-07-18 上海海雁医药科技有限公司 杂环取代的五并六元杂芳基衍生物、其药物组合物及应用与制备方法
CN120641406A (zh) * 2023-01-16 2025-09-12 上海海雁医药科技有限公司 杂环取代的含氮杂环衍生物、其药物组合物及应用与制备方法
KR20250167096A (ko) * 2023-04-07 2025-11-28 앨리콘 파머슈티컬 컴퍼니 리미티드 Aak1 억제제인 질소 함유 헤테로고리계 화합물
WO2025092928A1 (zh) * 2023-11-02 2025-05-08 西藏海思科制药有限公司 一种可抑制连接蛋白相关激酶1的化合物、制备及其用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
WO1993004169A1 (en) 1991-08-20 1993-03-04 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
US20030187026A1 (en) * 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
CA2507406A1 (en) 2002-11-05 2004-05-21 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of jak and other protein kinases
JP2007526324A (ja) * 2004-03-02 2007-09-13 スミスクライン・ビーチャム・コーポレイション Akt活性のある阻害剤
WO2007120593A1 (en) * 2006-04-12 2007-10-25 Wyeth Anilino-pyrimidine phenyl and benzothiophene analogs
MX2009008253A (es) * 2007-01-31 2009-10-12 Vertex Pharma Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
US8703953B2 (en) * 2012-03-09 2014-04-22 Bristol-Myers Squibb Company Aryl ether-base kinase inhibitors
EP3235499A3 (en) 2012-03-09 2018-01-17 Lexicon Pharmaceuticals, Inc. Inhibition of adaptor associated kinase 1 for the treatment of pain
US8901305B2 (en) * 2012-07-31 2014-12-02 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
JP2016509066A (ja) 2013-02-22 2016-03-24 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company アダプター関連キナーゼ1(aak1)の阻害剤としての5h−クロメノ[3,4−c]ピリジン
US10253027B2 (en) 2013-07-08 2019-04-09 Bristol-Myers Squibb Company Aryl lactam kinase inhibitors
MX2016002924A (es) 2013-09-11 2016-06-06 Squibb Bristol Myers Co Inhibidores de cinasa a base de eter arilico.
US20160333006A1 (en) 2014-01-29 2016-11-17 Bristol-Myers Squibb Company Aryl lacta kinase inhibitors
CA2937501A1 (en) 2014-01-31 2015-08-06 Bristol-Myers Squibb Company Quinoline-based kinase inhibitors
HRP20181899T1 (hr) 2014-04-02 2019-01-11 Bristol-Myers Squibb Company Biaril inhibitori kinaze
US20170239249A1 (en) 2014-09-30 2017-08-24 Bristol-Myers Squibb Company Quinazoline-based kinase inhibitors
ES2740224T3 (es) 2015-04-10 2020-02-05 Bristol Myers Squibb Co 6H-isocromeno[3,4-c]piridinas y benzo[c][1,7]naftiridin-6-(5H)-onas como inhibidores de la cinasa asociada a adaptador 1 (AAK1)
US10544120B2 (en) * 2015-10-01 2020-01-28 Bristol-Myers Squibb Company Biaryl kinase inhibitors
US10246469B2 (en) 2015-10-01 2019-04-02 Bristol-Myers Squibb Company Biaryl kinase inhibitors
EP3818007B1 (en) 2018-07-06 2025-04-16 Liqui-Box Corporation Dispensing probe for dispensing flowable material

Similar Documents

Publication Publication Date Title
JP2017511329A5 (cg-RX-API-DMAC7.html)
JP2018537408A5 (cg-RX-API-DMAC7.html)
NZ609955A (en) Sgc stimulators
ES2675760T3 (es) Compuestos terapéuticamente activos y métodos de uso de los mismos
JP5367707B2 (ja) Dhodh阻害剤としてのアザビフェニルアミノ安息香酸誘導体
JP2016523977A5 (cg-RX-API-DMAC7.html)
JP2016525076A5 (cg-RX-API-DMAC7.html)
NZ604004A (en) Pyridone and aza-pyridone compounds and methods of use
JP2016525075A5 (cg-RX-API-DMAC7.html)
US10376510B2 (en) 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
JP2020502111A5 (cg-RX-API-DMAC7.html)
JP2015172062A5 (cg-RX-API-DMAC7.html)
HRP20180546T1 (hr) Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti
JP2017530962A5 (cg-RX-API-DMAC7.html)
JP2011503230A5 (cg-RX-API-DMAC7.html)
RU2014124953A (ru) Производные аминопиридина в качестве модуляторов богатой лейцином повторной киназы 2 (lrrk2)
JP2016522232A5 (cg-RX-API-DMAC7.html)
JP2012525395A5 (cg-RX-API-DMAC7.html)
RU2019121871A (ru) Новые производные фенилпропионовой кислоты и их применение
JP2013543480A5 (cg-RX-API-DMAC7.html)
CA2624602A1 (en) Process for preparing 6-substituted-7-azaindoles
JP2017523214A5 (cg-RX-API-DMAC7.html)
JP2013500997A5 (cg-RX-API-DMAC7.html)
RU2016102313A (ru) Биарильные производные в качестве агонистов gpr120
JP2017504652A5 (cg-RX-API-DMAC7.html)